ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001365617

Heron Patrick J

CIK 0001365617 Name as filed on the most recent filing

Filed as Heron Patrick J (42)

57 transaction lines · from 42 filings · filed 2015-04-22 to 2026-01-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

36 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-01-23 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 131,425 acquired 68.48 8,999,984.00 Form 4, filing 0001365617-26-000002
2025-09-26 MBX Biosciences, Inc.
MBX 		P, Open-market purchase 666,666 acquired 18.00 11,999,988.00 Form 4, filing 0001231919-25-000267
2025-06-13 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 2,646 acquired 13.08 34,610.47 Form 4, filing 0001415889-25-017576
2025-06-05 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 378 acquired 13.41 5,069.28 Form 4, filing 0001415889-25-015883
2025-06-04 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 1,890 acquired 13.32 25,177.45 Form 4, filing 0001415889-25-015883
2025-05-22 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 2,520 acquired 13.65 34,398.00 Form 4, filing 0001415889-25-014415
2025-05-21 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 2,520 acquired 13.66 34,423.20 Form 4, filing 0001415889-25-014415
2025-05-15 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 2,520 acquired 13.62 34,316.86 Form 4, filing 0001415889-25-013620
2025-05-14 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 6,300 acquired 13.76 86,691.15 Form 4, filing 0001415889-25-013137
2025-05-13 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 2,374 acquired 13.76 32,660.78 Form 4, filing 0001415889-25-013137
2025-05-09 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 6,300 acquired 13.60 85,691.34 Form 4, filing 0001415889-25-012768
2025-03-17 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 21 acquired 43.93 922.61 Form 4, filing 0001415889-25-008439
2025-03-14 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 528 acquired 44.11 23,291.40 Form 4, filing 0001415889-25-008439
2025-03-11 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 963 acquired 43.77 42,155.13 Form 4, filing 0001415889-25-007828
2025-03-10 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 758 acquired 42.66 32,339.46 Form 4, filing 0001415889-25-007828
2025-03-10 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 577 acquired 43.37 25,023.34 Form 4, filing 0001415889-25-007828
2025-03-07 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 580 acquired 43.21 25,064.41 Form 4, filing 0001415889-25-007540
2025-03-06 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 1,335 acquired 43.89 58,596.89 Form 4, filing 0001415889-25-007540
2025-03-05 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 267 acquired 44.54 11,893.52 Form 4, filing 0001415889-25-007260
2025-03-04 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 1,279 acquired 45.55 58,256.66 Form 4, filing 0001415889-25-007260
2025-03-04 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 56 acquired 45.96 2,573.74 Form 4, filing 0001415889-25-007260
2024-09-18 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 115 acquired 37.40 4,301.00 Form 4, filing 0001415889-24-023777
2024-09-16 MBX Biosciences, Inc.
MBX 		P, Open-market purchase 625,000 acquired 16.00 10,000,000.00 Form 4, filing 0000950170-24-107530
2024-09-06 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 230 acquired 41.58 9,563.01 Form 4, filing 0001415889-24-023154
2024-04-04 HilleVax, Inc.
HLVX 		P, Open-market purchase 8,850 acquired 14.50 128,325.00 Form 4, filing 0001415889-24-010490
2024-03-04 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 21,052 acquired 9.50 199,994.00 Form 4, filing 0001415889-24-007040
2023-11-09 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 2,910 acquired 28.30 82,353.00 Form 4, filing 0001209191-23-055180
2023-10-24 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 80,000 acquired 2.50 200,000.00 Form 4, filing 0001209191-23-053662
2023-09-13 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 2,625 acquired 31.02 81,424.88 Form 4, filing 0001209191-23-049614
2023-09-12 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 3,750 acquired 30.60 114,763.88 Form 4, filing 0001209191-23-049292
2023-09-11 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 4,687 acquired 30.30 142,027.35 Form 4, filing 0001209191-23-049292
2023-08-31 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 147,991 acquired 26.25 3,884,763.75 Form 4, filing 0001209191-23-048086
2022-08-05 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 250,000 acquired 20.00 5,000,000.00 Form 4, filing 0001209191-22-045014
2022-05-03 HilleVax, Inc.
HLVX 		P, Open-market purchase 1,764,706 acquired 17.00 30,000,002.00 Form 4, filing 0000899243-22-016310
2022-02-11 Alpine Immune Sciences, Inc.
ALPN 		P, Open-market purchase 112,665 acquired 7.10 799,989.10 Form 4, filing 0001209191-22-009821
2021-07-20 Imago BioSciences, Inc.
IMGO 		P, Open-market purchase 145,918 acquired 16.00 2,334,688.00 Form 4, filing 0001567619-21-013730
2021-07-20 Imago BioSciences, Inc.
IMGO 		P, Open-market purchase 41,582 acquired 16.00 665,312.00 Form 4, filing 0001567619-21-013730
2020-12-11 Frazier Lifesciences Acquisition Corp
FLAC 		P, Open-market purchase 1,000,000 acquired 10.00 10,000,000.00 Form 4, filing 0001104659-20-134761
2020-10-20 Tarsus Pharmaceuticals, Inc.
TARS 		P, Open-market purchase 312,500 acquired 16.00 5,000,000.00 Form 4, filing 0001209191-20-055425
2020-06-16 Vaxcyte, Inc.
PCVX 		P, Open-market purchase 250,000 acquired 16.00 4,000,000.00 Form 4, filing 0001209191-20-037076
2020-03-03 Passage BIO, Inc.
PASG 		P, Open-market purchase 550,000 acquired 18.00 9,900,000.00 Form 4, filing 0001209191-20-015654
2020-02-04 Arcutis Biotherapeutics, Inc.
ARQT 		P, Open-market purchase 500,000 acquired 17.00 8,500,000.00 Form 4, filing 0001209191-20-007104
2020-01-09 Entasis Therapeutics Holdings Inc.
ETTX 		S, Open-market sale 50,000 disposed 5.00 250,010.00 Form 4, filing 0001209191-20-003162
2019-10-29 Phathom Pharmaceuticals, Inc.
PHAT 		P, Open-market purchase 1,052,631 acquired 19.00 19,999,989.00 Form 4, filing 0001209191-19-054525
2019-07-22 Mirum Pharmaceuticals, Inc.
MIRM 		P, Open-market purchase 450,000 acquired 15.00 6,750,000.00 Form 4, filing 0001209191-19-043022
2019-01-18 Alpine Immune Sciences, Inc.
ALPN 		P, Open-market purchase 372,439 acquired 5.37 1,999,997.43 Form 4, filing 0001209191-19-004783
2018-09-28 Entasis Therapeutics Holdings Inc.
ETTX 		P, Open-market purchase 375,887 acquired 15.00 5,638,305.00 Form 4, filing 0001209191-18-053535
2018-06-25 Aptinyx Inc.
APTX 		P, Open-market purchase 150,000 acquired 16.00 2,400,000.00 Form 4, filing 0001104659-18-042315
2018-05-30 Iterum Therapeutics plc
ITRM 		P, Open-market purchase 354,949 acquired 13.00 4,614,337.00 Form 4, filing 0001209191-18-034197
2018-05-30 Iterum Therapeutics plc
ITRM 		P, Open-market purchase 101,150 acquired 13.00 1,314,950.00 Form 4, filing 0001209191-18-034197

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 36
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Heron Patrick J, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001365617

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.